Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,403
Closed -$294K 291
2022
Q2
$294K Buy
+1,403
New +$299K 0.01% 246
2020
Q4
Sell
-4,958
Closed -$850K 596
2020
Q3
$850K Buy
4,958
+638
+15% +$118K 0.02% 355
2020
Q2
$636K Hold
4,320
0.02% 352
2020
Q1
$636K Hold
4,320
0.02% 352
2019
Q4
$668K Sell
4,320
-430
-9% -$62K 0.02% 426
2019
Q3
$642K Sell
4,750
-786
-14% -$103K 0.01% 450
2019
Q2
$675K Buy
+5,536
New +$613K 0.01% 453
2018
Q4
Sell
-1,987
Closed -$229K 746
2018
Q3
$229K Sell
1,987
-2,443
-55% -$268K ﹤0.01% 744
2018
Q2
$459K Buy
+4,430
New +$448K 0.01% 664
2017
Q2
Sell
-11,800
Closed -$850K 959
2017
Q1
$850K Buy
11,800
+4,900
+71% +$339K 0.01% 811
2016
Q4
$428K Buy
6,900
+1,000
+17% +$61.2K 0.01% 669
2016
Q3
$382K Hold
5,900
0.01% 637
2016
Q2
$373K Hold
5,900
0.01% 720
2016
Q1
$341K Hold
5,900
0.01% 780
2015
Q4
$317K Hold
5,900
0.01% 755
2015
Q3
$301K Hold
5,900
0.01% 756
2015
Q2
$333K Hold
5,900
0.01% 800
2015
Q1
$424K Hold
5,900
0.01% 742
2014
Q4
$331K Hold
5,900
0.01% 771
2014
Q3
$291K Hold
5,900
0.01% 814
2014
Q2
$299K Hold
5,900
0.01% 839
2014
Q1
$264K Hold
5,900
0.01% 825
2013
Q4
$278K Hold
5,900
0.01% 770
2013
Q3
$312K Hold
5,900
0.01% 751
2013
Q2
$266K Buy
+5,900
New +$280K 0.01% 767

Other funds holding RMD

Barings's RMD Position: Q3 2022 in Review

Barings sold out of ResMed (RMD) in Q3 2022, closing a stake of 1,403 shares — an estimated $294K sold.

Barings first reported a position in RMD in Q2 2013 and held it in 25 quarters. The position peaked at $850K in Q3 2020. 667 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Barings reported no remaining ResMed position as of Q3 2022 after selling out during the quarter.
  • Barings sold 1,403 ResMed shares in Q3 2022, an estimated $294K.
  • Barings first reported a position in ResMed in Q2 2013 and held it in 25 quarters.
  • Barings's ResMed position peaked at $850K in Q3 2020.
  • 667 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Barings's 13F filing for Q3 2022, filed 14 Nov 2022.